Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2012, Article ID 164263, 8 pages
http://dx.doi.org/10.1155/2012/164263
Clinical Study

Oncologic Outcomes of Surgery in T3 Prostate Cancer: Experience of a Single Tertiary Center

1Department of Urology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
2Institute of Oncology, Vilnius University, 01122 Vilnius, Lithuania

Received 22 June 2011; Revised 12 September 2011; Accepted 6 October 2011

Academic Editor: Paolo Gontero

Copyright © 2012 D. Milonas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. V. Meng, E. P. Elkin, D. M. Latini, J. DuChane, and P. R. Carroll, “Treatment of patients with high risk localized prostate cancer: results from Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE),” Journal of Urology, vol. 173, no. 5, pp. 1557–1561, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. H. Van Poppel and S. Joniau, “An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer,” European Urology, vol. 53, no. 2, pp. 253–259, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Heidenreich, M. Bolla, S. Joniau et al., EAU guidelines on prostate cancer, 2011, http://www.uroweb.org/gls/pdf/08_Prostate_Cancer%20September%2022nd%202011.pdf.
  4. O. Yossepowitch, S. E. Eggener, A. M. Serio et al., “Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy,” European Urology, vol. 53, no. 5, pp. 950–959, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Spahn, S. Joniau, P. Gontero et al., “Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients,” European Urology, vol. 58, no. 1, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. B. M. Mian, P. Troncoso, K. Okihara et al., “Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone,” Journal of Urology, vol. 167, no. 4, pp. 1675–1680, 2002. View at Google Scholar · View at Scopus
  7. C. Y. Hsu, S. Joniau, R. Oyen, T. Roskams, and H. Van Poppel, “Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience,” European Urology, vol. 51, no. 1, pp. 121–129, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. Heidenreich, J. Bellmunt, M. Bolla et al., “EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease,” European Urology, vol. 59, no. 1, pp. 61–71, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. S. Gerber, R. A. Thisted, G. W. Chodak et al., “Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis,” European Urology, vol. 32, no. 4, pp. 385–390, 1997. View at Google Scholar · View at Scopus
  10. D. Van den Ouden, W. C. J. Hop, and F. H. Schröder, “Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy,” Journal of Urology, vol. 160, no. 4, pp. 1392–1397, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. S. I. Martinez de la Rva, J. B. López-Tomasety, R. M. Domínguez, E. Á. Cruz, and P. S. Blanco, “Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up,” Archivos Espanoles de Urologia, vol. 57, no. 7, pp. 679–692, 2004. View at Google Scholar
  12. J. F. Ward, J. M. Slezak, M. L. Blute, E. J. Bergstralh, and H. Zincke, “Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-Year outcome,” BJU International, vol. 95, no. 6, pp. 751–756, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Roach, J. Lu, M. V. Pilepich et al., “Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 3, pp. 609–615, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bolla, L. Collette, L. Blank et al., “Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial,” The Lancet, vol. 360, no. 9327, pp. 103–108, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Stephenson, M. W. Kattan, J. A. Eastham et al., “Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era,” Journal of Clinical Oncology, vol. 27, no. 26, pp. 4300–4305, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. J. F. Donohue, F. J. Bianco, K. Kuroiwa et al., “Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading,” Journal of Urology, vol. 176, no. 3, pp. 991–995, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Manoharan, V. G. Bird, S. S. Kim, F. Civantos, and M. S. Soloway, “Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8,” BJU International, vol. 92, no. 6, pp. 539–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Serni, L. Masieri, A. Minervini, A. Lapini, G. Nesi, and M. Carini, “Cancer progression after anterograde radical prostatectomy for pathologic Gleason score 8 to 10 and influence of concomitant variables,” Urology, vol. 67, no. 2, pp. 373–378, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. Tewari, G. Divine, P. Chang et al., “Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy-a propensity scoring approach,” Journal of Urology, vol. 177, no. 3, pp. 911–915, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus